0001209191-22-003890.txt : 20220119
0001209191-22-003890.hdr.sgml : 20220119
20220119202733
ACCESSION NUMBER: 0001209191-22-003890
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220114
FILED AS OF DATE: 20220119
DATE AS OF CHANGE: 20220119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Edwards Larry G.
CENTRAL INDEX KEY: 0001733062
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 22540336
MAIL ADDRESS:
STREET 1: C/O TETRAPHASE PHARMACEUTICALS, INC.
STREET 2: 480 ARSENAL STREET, SUITE 110
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 JONES ROAD, SUITE 400
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-715-3600
MAIL ADDRESS:
STREET 1: 201 JONES ROAD, SUITE 400
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-14
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001733062
Edwards Larry G.
C/O LA JOLLA PHARMACEUTICAL COMPANY
201 JONES ROAD, SUITE 400
WALTHAM
MA
02451
0
1
0
0
Chief Executive Officer
Common Stock
2022-01-14
4
A
0
273
4.182
A
6138
D
Employee Stock Option (Right to Buy)
4.92
2022-01-14
4
A
0
273
0.00
A
2032-01-14
Common Stock
273
273
D
These shares were acquired on 1/14/2022 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
The stock options vest and become exercisable with respect to 25% of the underlying shares on the one-year anniversary of the grant date and then vest and become exercisable ratably on a monthly basis over the next three years.
/s/ Larry Edwards
2022-01-19